Literature DB >> 16489337

3' UTR seed matches, but not overall identity, are associated with RNAi off-targets.

Amanda Birmingham1, Emily M Anderson, Angela Reynolds, Diane Ilsley-Tyree, Devin Leake, Yuriy Fedorov, Scott Baskerville, Elena Maksimova, Kathryn Robinson, Jon Karpilow, William S Marshall, Anastasia Khvorova.   

Abstract

Off-target gene silencing can present a notable challenge in the interpretation of data from large-scale RNA interference (RNAi) screens. We performed a detailed analysis of off-targeted genes identified by expression profiling of human cells transfected with small interfering RNA (siRNA). Contrary to common assumption, analysis of the subsequent off-target gene database showed that overall identity makes little or no contribution to determining whether the expression of a particular gene will be affected by a given siRNA, except for near-perfect matches. Instead, off-targeting is associated with the presence of one or more perfect 3' untranslated region (UTR) matches with the hexamer or heptamer seed region (positions 2-7 or 2-8) of the antisense strand of the siRNA. These findings have strong implications for future siRNA design and the application of RNAi in high-throughput screening and therapeutic development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489337     DOI: 10.1038/nmeth854

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  335 in total

1.  Vectors and parameters that enhance the efficacy of RNAi-mediated gene disruption in transgenic Drosophila.

Authors:  Benjamin Haley; Bryon Foys; Michael Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-04       Impact factor: 11.205

2.  A homozygous mutant embryonic stem cell bank applicable for phenotype-driven genetic screening.

Authors:  Kyoji Horie; Chikara Kokubu; Junko Yoshida; Keiko Akagi; Ayako Isotani; Akiko Oshitani; Kosuke Yusa; Ryuji Ikeda; Yue Huang; Allan Bradley; Junji Takeda
Journal:  Nat Methods       Date:  2011-10-23       Impact factor: 28.547

Review 3.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

4.  Identification of c-Myb Target Genes in K562 Cells Reveals a Role for c-Myb as a Master Regulator.

Authors:  Petra Isabel Lorenzo; Elen Margrethe Brendeford; Siv Gilfillan; Alexey A Gavrilov; Marit Leedsak; Sergey V Razin; Ragnhild Eskeland; Thomas Sæther; Odd Stokke Gabrielsen
Journal:  Genes Cancer       Date:  2011-08

5.  Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells.

Authors:  Merril C Curry; Nicole A Luk; Paraic A Kenny; Sarah J Roberts-Thomson; Gregory R Monteith
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

6.  Dual-targeting siRNAs.

Authors:  Katrin Tiemann; Britta Höhn; Ali Ehsani; Stephen J Forman; John J Rossi; Pål Saetrom
Journal:  RNA       Date:  2010-04-21       Impact factor: 4.942

7.  Reduced seed region-based off-target activity with lentivirus-mediated RNAi.

Authors:  Richard A Klinghoffer; Jill Magnus; Janell Schelter; Michele Mehaffey; Casey Coleman; Michele A Cleary
Journal:  RNA       Date:  2010-03-26       Impact factor: 4.942

Review 8.  Systems biology in immunology: a computational modeling perspective.

Authors:  Ronald N Germain; Martin Meier-Schellersheim; Aleksandra Nita-Lazar; Iain D C Fraser
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

9.  Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease.

Authors:  Ryan L Boudreau; Ryan M Spengler; Beverly L Davidson
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

10.  Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.

Authors:  Silvana Konermann; Peter Lotfy; Nicholas J Brideau; Jennifer Oki; Maxim N Shokhirev; Patrick D Hsu
Journal:  Cell       Date:  2018-03-15       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.